A case series of thoracic paravertebral blocks using a combination of ropivacaine, clonidine, epinephrine, and dexamethasone

J Clin Anesth. 2012 Dec;24(8):664-7. doi: 10.1016/j.jclinane.2012.05.005.

Abstract

Five patients who underwent surgery for breast cancer were followed for 6 days after placement of a multiple-injection, one-time paravertebral block. Data were collected on patient satisfaction, analgesic consumption, side effects, and complications. Ropivacaine as a sole agent in paravertebral blocks has a clinical duration of up to 6 hours. The addition of epinephrine, clonidine, and dexamethasone prolonged the clinical duration considerably.

Publication types

  • Case Reports

MeSH terms

  • Amides / administration & dosage
  • Amides / adverse effects
  • Analgesics / administration & dosage*
  • Anesthetics, Combined / administration & dosage*
  • Anesthetics, Combined / adverse effects
  • Anesthetics, Local / administration & dosage*
  • Anesthetics, Local / adverse effects
  • Breast Neoplasms / surgery
  • Clonidine / administration & dosage
  • Clonidine / adverse effects
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Epinephrine / administration & dosage
  • Epinephrine / adverse effects
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Nerve Block / adverse effects
  • Nerve Block / methods*
  • Patient Satisfaction
  • Ropivacaine
  • Thoracic Vertebrae
  • Time Factors

Substances

  • Amides
  • Analgesics
  • Anesthetics, Combined
  • Anesthetics, Local
  • Ropivacaine
  • Dexamethasone
  • Clonidine
  • Epinephrine